Search

Your search keyword '"Zai G"' showing total 123 results

Search Constraints

Start Over You searched for: Author "Zai G" Remove constraint Author: "Zai G"
123 results on '"Zai G"'

Search Results

1. Identification of VRK1 as a Novel Potential Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma

2. Trichotillomania: the impact of treatment history on the outcome of an Internet-based intervention

5. Correlation between triglyceride-glucose index and atherosclerosis in type 2 diabetes mellitus

6. Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis

11. Analysis of shared heritability in common disorders of the brain

12. Whole-exome sequencing in obsessive-compulsive disorder identifies rare mutations in immunological and neurodevelopmental pathways

25. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

26. Analysis of shared heritability in common disorders of the brain

27. Summaries From The XIX World Congress of Psychiatric Genetics, Washington, DC, September 10–14, 2011

28. Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behaviour in schizophrenia

29. Genetic and polygenic investigation of heart rate variability to identify biomarkers associated with Anxiety disorders.

30. Rare de novo damaging DNA variants are enriched in attention-deficit/hyperactivity disorder and implicate risk genes.

31. Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling.

32. The role of small dense LDL-C/large buoyant LDL-C ratio as an independent risk factor in patients with type 2 diabetes mellitus and metabolic syndrome

33. Latin American Trans-ancestry INitiative for OCD genomics (LATINO): Study protocol.

34. Investigating the association of anxiety disorders with heart rate variability measured using a wearable device.

35. Genome-wide association study identifies 30 obsessive-compulsive disorder associated loci.

36. Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia.

37. Toward personalized circuit-based closed-loop brain-interventions in psychiatry: using symptom provocation to extract EEG-markers of brain circuit activity.

38. White matter volume and myelin oligodendrocyte glycoprotein (MOG) microsatellites in pediatric obsessive-compulsive disorder.

39. The therapygenetics of anxiety disorders.

40. Latin American Trans-ancestry INitiative for OCD genomics (LATINO): Study Protocol.

41. Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study.

43. Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial.

44. Genetics of social anxiety disorder: a systematic review.

45. Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial.

46. Changes in RNA expression levels during antidepressant treatment: a systematic review.

47. Genetics of human startle reactivity: A systematic review to acquire targets for an anxiety endophenotype.

48. An association of Myelin Oligodendrocyte Glycoprotein (MOG) gene variants with white matter volume in pediatric obsessive-compulsive disorder.

49. Pharmacogenetics of Obsessive-Compulsive Disorder: An Evidence-Update.

50. Review and Consensus on Pharmacogenomic Testing in Psychiatry.

Catalog

Books, media, physical & digital resources